Idiopathic membranous nephropathy associated to cyclosporine toxicity.: Prognosis and other inmunosupresive treatments

被引:0
|
作者
Díaz, ABM [1 ]
Aguilar, P [1 ]
机构
[1] Hosp Gen Univ La Fe, Serv Nefrol, Valencia 46009, Spain
来源
NEFROLOGIA | 2004年 / 24卷
关键词
membranous nephropathy; cyclosporine A; nephrotoxicity; inmunosupresive treatment;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 32 year-old male patient was admitted at our department presenting microhematuria and full nephrotic syndrome in april 1995. A percutaneus kidney biopsy proved a stage I-II membranous nephropathy and an eight-week course with oral prednisone was initiated without response. Then, oral ciclosporine A (3.5 mg/kg/day) was given and after 5 weeks of treatment, remmision of the nephrotic syndrome was observed but creatinine raised to 1.6 mg/dl, normalizing after reducing the dose of ciclosporine A. We discuss the settings, prognostic and therapeutic alternatives for idiopathic membranous nephropathy.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [21] Idiopathic membranous nephropathy associated with polycystic kidney disease
    Severin Kengne-Wafo
    Laura Massella
    Francesca Diomedi-Camassei
    Francesco Emma
    Pediatric Nephrology, 2010, 25 : 961 - 963
  • [22] A RETROSPECTIVE ANALYSIS OF LOW-DOSE CYCLOSPORINE A MONOTHERAPY IN IDIOPATHIC MEMBRANOUS NEPHROPATHY
    Zhou, F.
    Zheng, D.
    Wang, S.
    Cui, Z.
    Liu, G.
    Zhao, M.
    NEPHROLOGY, 2016, 21 : 233 - 233
  • [23] Effect of cyclosporine therapy on idiopathic membranous nephropathy presented with refractory nephrotic syndrome
    Iida H.
    Naito T.
    Sakai N.
    Aoki S.
    Clinical and Experimental Nephrology, 2000, 4 (1) : 81 - 85
  • [24] LONG-TERM CYCLOSPORINE-A THERAPY FOR SEVERE IDIOPATHIC MEMBRANOUS NEPHROPATHY
    ROSTOKER, G
    BELGHITI, D
    BENMAADI, A
    REMY, P
    LANG, P
    WEIL, B
    LAGRUE, G
    NEPHRON, 1993, 63 (03): : 335 - 341
  • [25] Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan
    Shiiki, H
    Saito, T
    Nishitani, Y
    Mitarai, T
    Yorioka, N
    Yoshimura, A
    Yokoyama, H
    Nishi, S
    Tomino, Y
    Kurokawa, K
    Sakai, H
    KIDNEY INTERNATIONAL, 2004, 65 (04) : 1400 - 1407
  • [26] Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy
    Laluck, BJ
    Cattran, DC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (06) : 1026 - 1032
  • [27] Comparison of Ultrastructural Features Between Patients with Mercury-associated Membranous Nephropathy and Idiopathic Membranous Nephropathy
    Qin, Ai-bo
    Lin, Zi-shan
    Wang, Su-xia
    Wang, Hui
    Cui, Zhao
    Zhou, Fu-de
    Zhao, Ming-hui
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (03): : 327 - 335
  • [28] COMPARISON OF ULTRASTRUCTURE FEATURES BETWEEN PATIENTS WITH MERCURY-ASSOCIATED MEMBRANOUS NEPHROPATHY AND IDIOPATHIC MEMBRANOUS NEPHROPATHY
    Qin, Aibo
    Lin, Zishan
    Zhou, Fude
    Zhao, Minghui
    Wang, Suxia
    Cui, Zhao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 427 - 427
  • [29] LONG-TERM PROGNOSIS OF 160 PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY AND NEPHROTIC SYNDROME, AND EFFICACY OF COMBINATION THERAPY WITH CORTICOSTEROID AND CYCLOSPORINE
    Tanaka, Hiroaki
    Fujii, Takayuki
    Kiso, Kayoko
    Koshizaka, Junya
    Yamauchi, Nobuaki
    Shinozaki, Mizuki
    Saito, Kaiji
    Morimoto, Mayu
    Terasaki, Noriko
    Suzuki, Satoshi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 499 - 500
  • [30] ARE THERE OTHER OPTIONS TO THE TREATMENT OF IDIOPATHIC MEMBRANOUS NEPHROPATHY? AN INTRODUCTION TO OUR EXPERIENCE
    Giammarresi, Carlo
    Tortorici, Calogera
    Ferrantelli, Angelo
    Bono, Luisa
    Pulizzi, Roberto
    Rotolo, Ugo
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A38 - A38